Conference paper

HYPERPROLACTINAEMIA WITH AMISULPRIDE

Klementina Ružić orcid.org/0000-0002-4696-5102 ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Tanja Grahovac ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Mirjana Graovac ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Elizabeta Dadić-Hero ; Community Primary Health Centre, Primorsko-goranska county, Croatia, Department of Social Medicine and Epidemiology, School of Medicine, Rijeka, Croatia
Dubravka Šepić-Grahovac ; Policlinic for Neurology and Psychiatry
Vladimir Sabljić ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia

Abstract

Psychopharmaca are used in treatment of psychiatric illnesses and disorders, among other therapeutic possibilities. The
choice of the psychopharmaca is determined by the specific psychopathology of the patient, within the diagnostic categories,
according to the current classification of diseases and disorders. With the advances in pharmaco industry, the range of drugs
used in the everyday clinical practice is occurring at a very rapid pace.
Antipsychotic medications are used in treatment of mainly psychotic disorders. However, the new generation of
antipsychotics, due to their specific receptor affinities, is sometimes used in treatment of affective disorders as well.
We are reporting a case of a female patient who was hospitalized several times. Amisulpride was introduced in the
treatment and due to a series of unfortunate events and changes that followed (i. e. frequent hospitalizations and changes of
therapists, different mental institutions) dose of amisulpride was gradually increased to its antipsychotic doses, which did not
help achieve therapeutic benefits, but serious side effects.

Keywords

mixed anxiety; depressive disorder; amisulpride; hyperprolactinaemia

Hrčak ID:

76537

URI

https://hrcak.srce.hr/76537

Publication date:

31.3.2011.

Visits: 1.566 *